Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by DA Holdford
Impacts of Black Box Warning, National Coverage Determination, and Risk Evaluation and Mitigation Strategies on the Inpatient On-Label and Off-Label Use of Erythropoiesis-Stimulating Agents
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Methylphenidate Off-Label Use and Safety
SpringerPlus
Multidisciplinary
Search Strategies to Identify Reports on “Off-Label” Drug Use in EMBASE
BMC Medical Research Methodology
Epidemiology
Health Informatics
Reasons for and Frequency of Off - Label Drug Use
Medicinski Pregled
Medicine
The FDA Black Box Warning Does Reduce the Use of Erythropoietin Stimulating Agents and Increases Blood Transfusions in Insured, Low Income Cancer Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Innovation and Off‐label Use, the French Case and More
British Journal of Clinical Pharmacology
Pharmacology
Off-Label Use of Approved Drugs
Nature Reviews Clinical Oncology
Oncology
Warning Label Placement: The Difference Effect of Social Risk and Health Risk Consequences
European Research Studies Journal
Management
Finance
Business
Economics
Accounting
Econometrics
«Off Label Use»: Nouvelles Recommandations
Bulletin des Médecins Suisses
Off-Label Use of Medicinal Products - Legal Rules and Practices
Acta Poloniae Pharmaceutica
Pharmacology
Pharmaceutical Science
